Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fimbriae (singular: fimbria) are short, hair-like, filamentous protein appendages on the surface of many bacteria, especially Gram-negative species such as Escherichia coli and Staphylococcus. They are composed mainly of pilin protein. Fimbriae are primarily involved in adhesion—the ability for the bacterium to attach to host cells, surfaces, or other bacteria. This adherence is critical for colonization, invasion, and biofilm formation, underlying their role in the pathogenesis of various infectious diseases such as urinary tract infections, bacterial meningitis, and gonorrhea. Unlike pili, which are often associated with genetic exchange (conjugation), fimbriae do not mediate DNA transfer but are mainly tissue adhesins. Structurally, fimbriae are shorter and more numerous than pili or flagella, with each bacterial cell potentially bearing hundreds to thousands of fimbriae. The terminal regions often contain specific adhesin proteins that enable a "lock-and-key" interaction with host epithelial receptors[1][3][5][7][8][9].\n\n**Key notes on the structured fields and caveats:**\n- "Fimbriae" is not a single molecular target or receptor, but a broad structural class of bacterial surface appendage, assembled from pilin and accessory proteins. There is no single "Fimbriae" molecule or gene, rather, numerous types exist, each encoded by distinct gene clusters (e.g., type 1 fimbriae, P fimbriae).\n- It is not a canonical therapeutic target like a receptor or enzyme but a collective structure found in various bacteria. Specific adhesins (e.g., FimH for type 1 fimbriae in E. coli) are more often targeted for intervention than "fimbriae" in general[6].\n- No common abbreviation exists; "fimbriae" is used in literature, with the singular "fimbria."\n- "Fimbriae" should not be used as a precise molecular drug target entry; thus, "is_incorrect: true."\n\nFor drug targeting or biomarker queries, refer instead to specific fimbrial adhesins or subunits (e.g., "FimH" in uropathogenic E. coli) rather than the collective term "fimbriae"[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fimbria (bacterial).